CytomX Therapeutics
SOUTH SAN FRANCISCO, CA · Founded 2010 · CIK 0001501989 · Biotech · Public
Conditionally activated masked biologic therapeutics that are activated within the tumor microenvironment
cytomx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $143M
- 9 Form D · Aug 2023
- 38 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 18 granted · 22 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20092011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 5 same day | Form D · SEC | $524,994 | |
| Private capital raised· 2 of 5 same day | Form D · SEC | $2,660,000 | |
| Private capital raised· 3 of 5 same day | Form D · SEC | $10,000,000 | |
| Private capital raised· 4 of 5 same day | Form D · SEC | $652,903 | |
| Private capital raised· 5 of 5 same day | Form D · SEC | $102,097 | |
| Private capital raised | Form D · SEC | $12,599,999 | |
| Private capital raised | Form D · SEC | $16,499,999 | |
| Private capital raised | Form D · SEC | $69,999,999 | |
| Private capital raised | Form D · SEC | $30,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1979 | GORDIAN BIOTECHNOLOGY, INC. | — | — |
| 1980 | ARCATO LABORATORIES, INC. | — | — |
| 1981 | Corxel | — | — |
| 1982 | CytomX Therapeutics | — | $143M |
| 1983 | POP ART, INC. | — | $1.0M |
| 1984 | NEURAEGIS INC | — | — |
| 1985 | C4 Therapeutics | — | $70M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Alan AshworthDirector
- Marcia BelvinExecutive Officer
- Wayne ChuExecutive Officer
- Neil ExterDirector
- Halley GilbertDirector
- Frederick GluckDirector · Executive Officer
- Alan HeegerDirector
- Charles HomcyDirector
- Hoyoung HuhDirector
- Rachel HumphreyDirector
- Elaine JonesDirector
- Jeff LandauExecutive Officer
- Sean McCarthyDirector · Executive Officer
- James MeyersDirector
- Mani MohindruDirector
- Chris OgdenExecutive Officer
- Fletcher PayneExecutive Officer
- Michael PfauExecutive Officer
- Lloyd RowlandExecutive Officer
- Tim ShannonDirector
- Nancy StaglianoDirector · Executive Officer
- Gary WilcoxDirector
- Matthew YoungDirector
Patents
- Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereofapplication
- Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereofgranted
- Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereofgranted
- Protease-cleavable Substrates And Methods Of Use Thereofapplication
- Matrix Metalloprotease-cleavable And Serine Or Cysteine Protease-cleavable Substrates And Methods Of Use Thereofapplication
- Matrix Metalloprotease-cleavable And Serine Or Cysteine Protease-cleavable Substrates And Methods Of Use Thereofgranted
- Antibodies, Activatable Antibodies, Bispecific Antibodies, And Bispecific Activatable Antibodies And Methods Of Use Thereofapplication
- Protease-cleavable Substrates And Methods Of Use Thereofgranted
- Protease-cleavable Substrates And Methods Of Use Thereofgranted
- Matrix Metalloprotease-cleavable And Serine Or Cysteine Protease-cleavable Substrates And Methods Of Use Thereofgranted
- Protease-cleavable Moieties And Methods Of Use Thereofapplication
- Protease-cleavable Substrates And Methods Of Use Thereofgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.